Pediatric soft tissue sarcomas.
Soft tissue sarcomas are the sixth most common cancer in children and collectively account for about seven percent of all pediatric cancers. The development of increasingly intensive, multimodality treatment protocols for these tumors has led to a steady increase in cure rates for these neoplasms, especially for rhabdomyosarcoma, the most common pediatric soft tissue sarcoma. This article provides an overview of the basic biology, clinical management, and clinical research for pediatric soft tissue sarcomas.
Solid Tumor Section, National Cancer Institute, Bethesda, Maryland.
L H
LH
Wexler
L J
LJ
Helman
D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D012208:Rhabdomyosarcoma / Q000175:diagnosis / Q000556:secondary / Q000628:therapy; D012509:Sarcoma / Q000175:diagnosis* / Q000556:secondary / Q000628:therapy; D012983:Soft Tissue Neoplasms / Q000175:diagnosis* / Q000628:therapy; D016896:Treatment Outcome